Published in Oncogene on January 17, 2011
Requirement for interaction of PI3-kinase p110α with RAS in lung tumor maintenance. Cancer Cell (2013) 1.95
Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. Cancer Cell (2016) 1.46
Nicotine does not enhance tumorigenesis in mutant K-ras-driven mouse models of lung cancer. Cancer Prev Res (Phila) (2011) 1.27
Opposing functions of Akt isoforms in lung tumor initiation and progression. PLoS One (2014) 0.99
Modulation of the mevalonate pathway by akt regulates macrophage survival and development of pulmonary fibrosis. J Biol Chem (2014) 0.93
Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells. Oncotarget (2014) 0.91
Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN. J Biol Chem (2014) 0.89
The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines. Tumour Biol (2013) 0.89
A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice. Carcinogenesis (2011) 0.87
Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma. BMC Cancer (2015) 0.87
Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. J Biol Chem (2012) 0.86
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells. Oncotarget (2015) 0.84
Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration. Cell Rep (2015) 0.80
Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells. Int J Oncol (2016) 0.80
PIK3CAH1047R Accelerates and Enhances KRASG12D-Driven Lung Tumorigenesis. Cancer Res (2015) 0.78
Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis. Oncotarget (2016) 0.78
Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14. J Biol Chem (2013) 0.77
Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formation. Sci Rep (2015) 0.76
Patent controversies and court cases: cancer diagnosis, therapy and prevention. Cancer Biol Ther (2012) 0.76
Akt as a target for cancer therapy: more is not always better (lessons from studies in mice). Br J Cancer (2017) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
AKT/PKB signaling: navigating downstream. Cell (2007) 31.26
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science (2001) 11.22
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature (2007) 10.98
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature (2001) 10.56
Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem (2001) 7.10
Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell (2007) 6.44
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell (2003) 5.17
Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol (2002) 4.77
Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol (2005) 4.00
Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell (2006) 3.83
Identification of a tumour suppressor network opposing nuclear Akt function. Nature (2006) 3.68
Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res (2009) 3.56
Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res (2007) 3.13
Genomic instability in Gadd45a-deficient mice. Nat Genet (1999) 3.01
Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol (2001) 2.90
The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice. Genes Dev (2006) 2.76
Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol (1996) 2.69
Akt1 governs breast cancer progression in vivo. Proc Natl Acad Sci U S A (2007) 2.67
A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer (2008) 2.63
The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle (2009) 2.62
Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol Cell Biol (2006) 2.03
K-ras as a target for cancer therapy. Biochim Biophys Acta (2005) 1.74
Perifosine: update on a novel Akt inhibitor. Curr Oncol Rep (2009) 1.73
The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas. Br J Cancer (2009) 1.70
Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. Cancer Res (2002) 1.69
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. Cell Cycle (2007) 1.65
Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. J Clin Oncol (2005) 1.64
The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma. Pigment Cell Melanoma Res (2009) 1.62
Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumors. Clin Cancer Res (2007) 1.46
Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer Metastasis Rev (2005) 1.46
Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Res (2004) 1.45
The potential role of Akt phosphorylation in human cancers. Int J Biol Markers (2008) 1.44
Akt as a therapeutic target in cancer. Expert Opin Ther Targets (2008) 1.41
Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol Cell Biol (2003) 1.38
Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res (1989) 1.38
Enhancement of tumor formation in mouse lung by dietary butylated hydroxytoluene. Toxicology (1981) 1.26
A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study. Invest New Drugs (2005) 1.22
AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K. Oncogene (2009) 1.20
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. PLoS One (2008) 1.14
SnapShot: Ras Signaling. Cell (2008) 1.12
Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp Lung Res (1998) 1.03
Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. Mol Cell Biol (2009) 1.02
The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway. Biomaterials (2009) 0.99
Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. Am J Respir Crit Care Med (2008) 0.96
AKT1 E17 K pleckstrin homology domain mutation in urothelial carcinoma. Cancer Genet Cytogenet (2009) 0.88
Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice. Neoplasia (2008) 0.88
Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenic. Int J Cancer (2010) 0.84
Assessment of murine lung tumour development: a comparison of two techniques. Br J Biomed Sci (2001) 0.78
Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res (2001) 4.73
Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol (1991) 3.59
NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl (1996) 3.24
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene (1992) 2.64
A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol (2000) 2.35
An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature (1997) 2.29
Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest (1983) 2.12
Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res (1992) 1.86
Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene (1991) 1.79
Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med (1993) 1.66
Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis. Exp Lung Res (2000) 1.58
Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung. Cancer (1999) 1.49
Scientific basis for cancer prevention. Intermediate cancer markers. Cancer (1993) 1.47
Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial. J Natl Cancer Inst (1990) 1.42
Human lung small-cell carcinoma contains bombesin. Proc Natl Acad Sci U S A (1982) 1.39
Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res (1988) 1.24
p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res (1993) 1.23
Expression of CD44 in human lung tumors. Cancer Res (1994) 1.18
Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children. Hum Pathol (1984) 1.17
Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants. Cell Death Differ (2002) 1.15
Neuroendocrine cells and neuroendocrine neoplasms of the lung. Pathol Annu (1983) 1.13
Prevention of hemodialysis fistula thrombosis. Early detection of venous stenoses. Kidney Int (1989) 1.12
Distribution of [Met5]- and [Leu5]-enkephalin-, vasoactive intestinal polypeptide- and substance P-like immunoreactivities in human adrenal glands. Neuroscience (1980) 1.11
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines. J Natl Cancer Inst Monogr (1992) 1.08
The pathology of lung cancer--changing concepts and newer diagnostic techniques. Semin Oncol (1988) 1.08
Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res (1990) 1.07
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol (1994) 1.07
MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Res (1998) 1.04
Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res (1994) 1.02
Altered cJUN expression: an early event in human lung carcinogenesis. Cancer Res (1996) 1.02
Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol (1996) 1.02
An immunohistochemical and radioimmunological study of the distribution of [met5]- and [leu5]-enkephalin in the gastrointestinal tract. Neuroscience (1978) 1.01
Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. J Clin Oncol (1990) 1.01
Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells. Cell Death Dis (2012) 1.00
Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein. Oncogene (1998) 1.00
A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Cancer Res (1990) 1.00
GTP gamma S loading of endothelial cells stimulates phospholipase C and uncouples ATP receptors. Am J Physiol (1988) 1.00
Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region ("Askin tumor"). Am J Surg Pathol (1986) 0.98
The effects of low temperature and chloroquine on 125I-insulin degradation by the perfused rat liver. Arch Biochem Biophys (1981) 0.98
myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens. Cancer Res (1991) 0.97
Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol (1995) 0.96
Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers. Am J Respir Cell Mol Biol (1993) 0.94
Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol (1997) 0.94
Attenuation of pulmonary neuroendocrine differentiation in mice lacking Clara cell secretory protein. Lab Invest (2000) 0.93
Gastrin-releasing peptide gene-associated peptides are expressed in normal human fetal lung and small cell lung cancer: a novel peptide family found in man. J Clin Endocrinol Metab (1988) 0.92
Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium. Lung Cancer (1996) 0.92
Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ (1998) 0.92
Expression of the atrial natriuretic factor gene in small cell lung cancer tumors and tumor cell lines. J Natl Cancer Inst (1990) 0.91
Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab Invest (1992) 0.91
A neuropeptide in mammalian tissues with physalaemin-like immunoreactivity. Nature (1980) 0.89
Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival. Br J Cancer (2010) 0.89
Histochemical characterization of non-neuroendocrine tumors and neuroendocrine cell hyperplasia induced in hamster lung by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone with or without hyperoxia. Am J Pathol (1995) 0.88
Metabolism of leupeptin and its effect on autophagy in the perfused rat liver. Acta Biol Med Ger (1981) 0.88
Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res (1993) 0.87
Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers. Int J Cancer (1992) 0.87
K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer. Br J Cancer (1998) 0.87
Clara cell 10 kDa protein mRNA in normal and atypical regions of human respiratory epithelium. Int J Cancer (1994) 0.87
Hemodialysis without anticoagulation. One-year prospective trial in hospitalized patients at risk for bleeding. Am J Med (1987) 0.86
Effects of diethylnitrosamine on lung neuroendocrine cells. Exp Lung Res (1982) 0.86
Bronchiolization of the alveoli in lung cancer: pathology, patterns of differentiation and oncogene expression. Int J Cancer (1998) 0.86
A fatal episode of accidental methomyl poisoning. Clin Toxicol (1979) 0.86
Lung endocrine-like cells in hamsters treated with diethylnitrosamine: alterations in vivo and in cell culture. Proc Natl Acad Sci U S A (1981) 0.85
Paucity of beta 2-microglobulin expression on small cell lung cancer, bronchial carcinoids and certain other neuroendocrine tumors. Lab Invest (1986) 0.84
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer. J Cell Biochem Suppl (1996) 0.83
Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Chest (1997) 0.83
Venular endothelium in vitro: isolation and characterization. In Vitro Cell Dev Biol (1988) 0.83
Neural cell adhesion molecule expression and messenger RNA splicing patterns in lung cancer cell lines are correlated with neuroendocrine phenotype and growth morphology. Cancer Res (1991) 0.83
TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract. Int J Cancer (1995) 0.82
Genetic changes in contralateral bronchioloalveolar carcinomas of the lung. Oncology (2001) 0.82
Identification of insecticidal peptides from venom of the trap-door spider, Aptostichus schlingeri (Ctenizidae). Toxicon (1992) 0.82
NSE in neuroblastoma and other round cell tumors of childhood. Prog Clin Biol Res (1985) 0.82
Stimulation of hamster pulmonary neuroendocrine cells and associated peptides by repeated exposure to cigarette smoke. Am Rev Respir Dis (1989) 0.82
Isolation and identification of paralytic peptides from hemolymph of the lepidopteran insects Manduca sexta, Spodoptera exigua, and Heliothis virescens. J Biol Chem (1991) 0.81
Ceramide mediates nanovesicle shedding and cell death in response to phosphatidylinositol ether lipid analogs and perifosine. Cell Death Dis (2012) 0.81
Demonstration of Chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay. Cancer (1988) 0.81
A study of myc-related gene expression in small cell lung cancer by in situ hybridization. Am J Pathol (1988) 0.81
Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome. Cancer Res (1992) 0.81
Ectopic parathyroid tissue within the vagus nerve. Incidence and possible clinical significance. Arch Pathol Lab Med (1988) 0.80
Downregulation of p21/WAF1 expression by thymidylate synthase. Biochem Biophys Res Commun (2001) 0.80
Pulmonary nodules resembling bronchioloalveolar carcinoma in adolescent cancer patients. Mod Pathol (1988) 0.80
Pulmonary neuroepithelial bodies, neuroendocrine cells, and pulmonary tumors. Hum Pathol (1982) 0.79
Calcitonin as a marker for diethylnitrosamine-induced pulmonary endocrine cell hyperplasia in hamsters. Lab Invest (1984) 0.79
Cholinergic-nicotinic control of growth and secretion of cultured pulmonary neuroendocrine cells. Anat Rec (1993) 0.79
Immunolymphoscintigraphy of pulmonary and mediastinal lymph nodes in dogs: a new approach to lung cancer imaging. Cancer Res (1987) 0.79
Neuroendocrine carcinoma of skin with simultaneous cytokeratin expression. Ultrastruct Pathol (1984) 0.79
An MspI RFLP of the human AHR gene. Hum Mol Genet (1994) 0.78
Abnormal expression of the retinoblastoma gene in ovarian neoplasms and correlation to p53 and K-ras mutations. Gynecol Oncol (1995) 0.77
Time course of release into the medium of newly synthesized proteins by cultured aortic endothelial cells. Role of serum in preventing proteolytic degradation. Arteriosclerosis (1986) 0.77
Paralytic and insecticidal toxins from the funnel web spider, Hololena curta. Toxicon (1991) 0.77
Prenatal cholinergic stimulation of pulmonary neuroendocrine cells by nicotine. Acta Physiol Scand (1988) 0.77
Comparative studies of hamster calcitonin from pulmonary endocrine cells in vitro. Peptides (1988) 0.77
Tumor cell lines established in vitro: an independent prognostic factor for survival in non-small-cell lung cancer. Ann Intern Med (1990) 0.77
Prevention and early detection of lung cancer-clinical aspects. Lung Cancer (1997) 0.77
Corticotropin/beta-endorphin immunoreactivity in rat mast cells. Peptide or protease? Life Sci (1981) 0.76
Primary culture of the enteric nervous system from neonatal hamster intestine. Selection of vasoactive intestinal polypeptide-containing neurons. Gastroenterology (1988) 0.75
Expression of peptidyl-glycine alpha-amidating mono-oxygenase (PAM) enzymes in morphological abnormalities adjacent to pulmonary tumors. Am J Pathol (1996) 0.75
Candidate biomarkers for application as intermediate end points of lung carcinogenesis. J Cell Biochem Suppl (1992) 0.75
Interferon-mediated in vivo induction of beta 2-microglobulin on small-cell lung cancers and mid-gut carcinoids. Clin Immunol Immunopathol (1986) 0.75
Patterns of neoplasia in c-mos transgenic mice and their relevance to multiple endocrine neoplasia. Henry Ford Hosp Med J (1992) 0.75